Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuta Umezawa

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cureus|April 20, 2026
Quantitative Visualization of Console Behavior During Robot-Assisted Radical Prostatectomy Using the Da Vinci 5 System: A Case-Based Technical ReportYuta Umezawa, Go Kaneko, Daisuke Igarashi, et al.
Translational Andrology and Urology|May 19, 2020
A case of castration-resistant prostate cancer with liver metastases achieved a complete response by docetaxel chemotherapySuguru Shirotake, Yuta Umezawa, Takashi Okabe, et al.
In Vivo (Athens, Greece)|May 2, 2020
Efficacy of Nivolumab Plus Ipilimumab in a Patient With Renal Cell Carcinoma Concomitant With Cardiac Metastasis: A Case ReportSuguru Shirotake, Yuta Umezawa, Takashi Okabe, et al.
Plos One|October 20, 2022
Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy aloneKent Kanao, Takayuki Takahashi, Yuta Umezawa, et al.
Molecular and Clinical Oncology|April 23, 2019
Meningeal carcinomatosis from bladder cancer: A case report and review of the literatureYuta Umezawa, Suguru Shirotake, Go Kaneko, et al.
Cureus|February 10, 2025
A Case of Avelumab-Resistant Upper Urothelial Carcinoma Responding to PembrolizumabKotaro Yokota, Suguru Shirotake, Yu Miyama, et al.
Cureus|June 13, 2024
Choroidal Metastasis From Papillary Renal Cell Carcinomas: A Case Report and a Review of the LiteratureShinnosuke Hiruta, Go Kaneko, Yu Miyama, et al.
IJU Case Reports|May 5, 2022
Case Study: A Japanese patient with metastatic renal cell carcinoma who achieved long-term treatment-free survival with pembrolizumab and axitinib in the KEYNOTE-426 phase III trial of pembrolizumab and axitinib versus sunitinibKoshiro Nishimoto, Suguru Shirotake, Yu Miyama, et al.
Case Reports in Oncology|January 2, 2026
Long-Term Control after Intermittent Reintroduction of Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Case ReportKenta Fujii, Suguru Shirotake, Shohei Yamamura, et al.
Cancer Immunology, Immunotherapy : CII|February 4, 2025
Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinomaMaki Todo, Yodo Gatate, Shintaro Nakano, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cureus|April 20, 2026
Quantitative Visualization of Console Behavior During Robot-Assisted Radical Prostatectomy Using the Da Vinci 5 System: A Case-Based Technical ReportYuta Umezawa, Go Kaneko, Daisuke Igarashi, et al.
Translational Andrology and Urology|May 19, 2020
A case of castration-resistant prostate cancer with liver metastases achieved a complete response by docetaxel chemotherapySuguru Shirotake, Yuta Umezawa, Takashi Okabe, et al.
In Vivo (Athens, Greece)|May 2, 2020
Efficacy of Nivolumab Plus Ipilimumab in a Patient With Renal Cell Carcinoma Concomitant With Cardiac Metastasis: A Case ReportSuguru Shirotake, Yuta Umezawa, Takashi Okabe, et al.
Plos One|October 20, 2022
Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy aloneKent Kanao, Takayuki Takahashi, Yuta Umezawa, et al.
Molecular and Clinical Oncology|April 23, 2019
Meningeal carcinomatosis from bladder cancer: A case report and review of the literatureYuta Umezawa, Suguru Shirotake, Go Kaneko, et al.
Cureus|February 10, 2025
A Case of Avelumab-Resistant Upper Urothelial Carcinoma Responding to PembrolizumabKotaro Yokota, Suguru Shirotake, Yu Miyama, et al.
Cureus|June 13, 2024
Choroidal Metastasis From Papillary Renal Cell Carcinomas: A Case Report and a Review of the LiteratureShinnosuke Hiruta, Go Kaneko, Yu Miyama, et al.
IJU Case Reports|May 5, 2022
Case Study: A Japanese patient with metastatic renal cell carcinoma who achieved long-term treatment-free survival with pembrolizumab and axitinib in the KEYNOTE-426 phase III trial of pembrolizumab and axitinib versus sunitinibKoshiro Nishimoto, Suguru Shirotake, Yu Miyama, et al.
Case Reports in Oncology|January 2, 2026
Long-Term Control after Intermittent Reintroduction of Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Case ReportKenta Fujii, Suguru Shirotake, Shohei Yamamura, et al.
Cancer Immunology, Immunotherapy : CII|February 4, 2025
Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinomaMaki Todo, Yodo Gatate, Shintaro Nakano, et al.
Pageof 2